Intec Pharma Ltd. (NASDAQ:NTEC) and Matinas BioPharma Holdings Inc. (NYSEAMERICAN:MTNB) are two firms in the Biotechnology that compete against each other. Below is a comparison of their profitability, analyst recommendations, risk, dividends, institutional ownership, earnings and valuation.
Valuation and Earnings
Demonstrates Intec Pharma Ltd. and Matinas BioPharma Holdings Inc. earnings per share, top-line revenue and valuation.
Table 2 provides Intec Pharma Ltd. and Matinas BioPharma Holdings Inc.’s return on assets, return on equity and net margins.
Institutional and Insider Ownership
Institutional investors owned 39.64% of Intec Pharma Ltd. shares and 11.7% of Matinas BioPharma Holdings Inc. shares. Intec Pharma Ltd.’s share owned by insiders are 11.81%. Competitively, 0.7% are Matinas BioPharma Holdings Inc.’s share owned by insiders.
Here are the Weekly, Monthly, Quarterly, Half Yearly, Yearly and YTD Performance of both pretenders.
For the past year Intec Pharma